Home
CRDL
CRDL News

Latest Cardiol Therapeutics Inc. (CRDL) News on May 14, 2025

Cardiol Therapeutics Nominates Dr. Timothy Garnett to Its Board of Directors

Newsfile

15 days ago

Cardiol Therapeutics Nominates Dr. Timothy Garnett to Its Board of Directors

Cardiol Therapeutics Enrolls First Patient in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis

Newsfile

a month ago

Cardiol Therapeutics Enrolls First Patient in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis

We're Keeping An Eye On Cardiol Therapeutics' (TSE:CRDL) Cash Burn Rate

Simply Wall St.

a month ago

We're Keeping An Eye On Cardiol Therapeutics' (TSE:CRDL) Cash Burn Rate

Cardiol Therapeutics Announces Year-End 2024 Update on Operations

Newsfile

a month ago

Cardiol Therapeutics Announces Year-End 2024 Update on Operations

Cardiol Therapeutics to Present at TD Cowen 45th Annual Health Care Conference

Newsfile

2 months ago

Cardiol Therapeutics to Present at TD Cowen 45th Annual Health Care Conference

Cardiol Therapeutics Announces Publication of Research in the Journal of the American College of Cardiology: Basic to Translational Science That Supports Development of Its Proprietary Subcutaneous Drug Candidate, CRD-38, for the Treatment of Heart Failure

Newsfile

3 months ago

Cardiol Therapeutics Announces Publication of Research in the Journal of the American College of Cardiology: Basic to Translational Science That Supports Development of Its Proprietary Subcutaneous Drug Candidate, CRD-38, for the Treatment of Heart Failure

Cardiol Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference

Newsfile

3 months ago

Cardiol Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference

PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx™ Addressing Patients with Recurrent Pericarditis

GlobeNewswire

5 months ago

PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx™ Addressing Patients with Recurrent Pericarditis

Cardiol Therapeutics' Phase II MAvERIC-Pilot Clinical Results in Recurrent Pericarditis Presented at the American Heart Association Scientific Sessions 2024

Newsfile

6 months ago

Cardiol Therapeutics' Phase II MAvERIC-Pilot Clinical Results in Recurrent Pericarditis Presented at the American Heart Association Scientific Sessions 2024

Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index

GlobeNewswire

6 months ago

Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index

Cardiol Therapeutics to Advance CardiolRx(TM) into a Late-Stage Trial in Patients with Recurrent Pericarditis

Newsfile

7 months ago

Cardiol Therapeutics to Advance CardiolRx(TM) into a Late-Stage Trial in Patients with Recurrent Pericarditis

Cardiol Therapeutics Announces Exercise and Closing of Over-Allotment Option

Newsfile

7 months ago

Cardiol Therapeutics Announces Exercise and Closing of Over-Allotment Option

Cardiol Therapeutics Announces Closing of US$13.5 Million Public Offering of Common Shares

Newsfile

7 months ago

Cardiol Therapeutics Announces Closing of US$13.5 Million Public Offering of Common Shares

Cardiol Therapeutics Announces Pricing of Public Offering of Common Shares

Newsfile

7 months ago

Cardiol Therapeutics Announces Pricing of Public Offering of Common Shares

Cardiol Therapeutics Files Preliminary Prospectus Supplement for Proposed Public Offering of Common Shares

Newsfile

7 months ago

Cardiol Therapeutics Files Preliminary Prospectus Supplement for Proposed Public Offering of Common Shares

Cardiol Therapeutics Achieves Target Patient Enrollment in its Phase II ARCHER Trial Investigating CardiolRx(TM) for Acute Myocarditis

Newsfile

8 months ago

Cardiol Therapeutics Achieves Target Patient Enrollment in its Phase II ARCHER Trial Investigating CardiolRx(TM) for Acute Myocarditis

Cardiol Therapeutics Announces Completion of the MAvERIC Phase II Study in Recurrent Pericarditis with Results to be Presented at the American Heart Association Scientific Sessions 2024

Newsfile

8 months ago

Cardiol Therapeutics Announces Completion of the MAvERIC Phase II Study in Recurrent Pericarditis with Results to be Presented at the American Heart Association Scientific Sessions 2024

We're Keeping An Eye On Cardiol Therapeutics' (TSE:CRDL) Cash Burn Rate

Simply Wall St.

10 months ago

We're Keeping An Eye On Cardiol Therapeutics' (TSE:CRDL) Cash Burn Rate

Cardiol Therapeutics Reports Results of 2024 Annual General and Special Meeting of Shareholders

Newsfile

a year ago

Cardiol Therapeutics Reports Results of 2024 Annual General and Special Meeting of Shareholders

Cardiol Therapeutics to Webcast Virtual Annual General and Special Meeting of Shareholders on June 26th at 4:30 p.m. EDT

Newsfile

a year ago

Cardiol Therapeutics to Webcast Virtual Annual General and Special Meeting of Shareholders on June 26th at 4:30 p.m. EDT

ACCESSWIRE

a year ago

Hope on the Horizon: Results from MAvERIC-Pilot Show Heartfelt Progress for Patients

Cardiol Therapeutics Announces Positive Topline Data from its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis

Newsfile

a year ago

Cardiol Therapeutics Announces Positive Topline Data from its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

Yahoo Finance Video

a year ago

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

GlobeNewswire

a year ago

Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis

California seeks company profits in Big Oil climate lawsuit

Reuters

a year ago

California seeks company profits in Big Oil climate lawsuit

USA TODAY

a year ago

S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

GlobeNewswire

a year ago

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Business Wire

a year ago

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Business Wire

a year ago

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

GlobeNewswire

a year ago

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

Media Advisory - Prime Minister's itinerary for Sunday, June 9, 2024

CNW Group

a year ago

Media Advisory - Prime Minister's itinerary for Sunday, June 9, 2024

Industry Report: The Cannabis Company that Soared Nearly 100% This Year: What's Behind InterCure's Surge

ACCESSWIRE

a year ago

Industry Report: The Cannabis Company that Soared Nearly 100% This Year: What's Behind InterCure's Surge

Russia is doubling down on its de-dollarization efforts as Putin calls to reduce use of 'toxic' currencies

Business Insider

a year ago

Russia is doubling down on its de-dollarization efforts as Putin calls to reduce use of 'toxic' currencies

4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion Cohort in Wet AMD Patients with Severe Disease Activity & High Treatment Burden at the Clinical Trials at the Summit 2024 Meeting

GlobeNewswire

a year ago

4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion Cohort in Wet AMD Patients with Severe Disease Activity & High Treatment Burden at the Clinical Trials at the Summit 2024 Meeting

Nvidia May Be an Exciting Stock, but Its 10-for-1 Stock Split -- Like Most Stock Splits -- Is a Nothing Burger

Motley Fool

a year ago

Nvidia May Be an Exciting Stock, but Its 10-for-1 Stock Split -- Like Most Stock Splits -- Is a Nothing Burger

Unifor members vote to strike at Manitoba Hydro

CNW Group

a year ago

Unifor members vote to strike at Manitoba Hydro

Croatia beat Portugal in Euro 2024 warm-up friendly

AFP

a year ago

Croatia beat Portugal in Euro 2024 warm-up friendly

Mark Cuban explains how he helped turn 300 of his employees into millionaires

Business Insider

a year ago

Mark Cuban explains how he helped turn 300 of his employees into millionaires

Cardiol Therapeutics Announces Phase II ARCHER Trial Presented at the World Congress on Acute Heart Failure 2024

Newsfile

a year ago

Cardiol Therapeutics Announces Phase II ARCHER Trial Presented at the World Congress on Acute Heart Failure 2024

Canadian Investment Regulatory Organization Trading Halt - CRDL.WT.A

CNW Group

a year ago

Canadian Investment Regulatory Organization Trading Halt - CRDL.WT.A

Cardiol Therapeutics Announces Year-End 2023 Update on Operations

Newsfile

a year ago

Cardiol Therapeutics Announces Year-End 2023 Update on Operations

Cardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis

Newsfile

a year ago

Cardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis

Cardiol Therapeutics Granted Orphan Drug Designation for its Lead Drug Candidate for the Treatment of Pericarditis

Newsfile

a year ago

Cardiol Therapeutics Granted Orphan Drug Designation for its Lead Drug Candidate for the Treatment of Pericarditis

Innovid to Release Fourth Quarter & Full Year 2023 Financial Results on February 27th

Business Wire

a year ago

Innovid to Release Fourth Quarter & Full Year 2023 Financial Results on February 27th

Graham Corporation Announces Third Quarter Fiscal Year 2024 Financial Results Conference Call and Webcast

Business Wire

a year ago

Graham Corporation Announces Third Quarter Fiscal Year 2024 Financial Results Conference Call and Webcast

GuruFocus.com

a year ago

Orrstown Financial Services Inc (ORRF) Reports Record Annual Earnings for 2023

Cardiol Therapeutics Regains Compliance with all Applicable Listing Standards of The Nasdaq Capital Market

Newsfile

a year ago

Cardiol Therapeutics Regains Compliance with all Applicable Listing Standards of The Nasdaq Capital Market

GoldMining Subsidiary, U.S. GoldMining, Announces Confirmatory Results, Including Highest Drill Intercept to Date at the Whistler Gold-Copper Project, Alaska

PR Newswire

a year ago

GoldMining Subsidiary, U.S. GoldMining, Announces Confirmatory Results, Including Highest Drill Intercept to Date at the Whistler Gold-Copper Project, Alaska

Orrstown Financial Services (ORRF) Q4 Earnings Lag Estimates

Zacks

a year ago

Orrstown Financial Services (ORRF) Q4 Earnings Lag Estimates

Eagle Bancorp Montana Earns $2.2 Million, or 0.28 per Diluted Share, in the Fourth Quarter of 2023 and $10.1 Million, or $1.29 per Diluted Share, for the Year 2023

GlobeNewswire

a year ago

Eagle Bancorp Montana Earns $2.2 Million, or 0.28 per Diluted Share, in the Fourth Quarter of 2023 and $10.1 Million, or $1.29 per Diluted Share, for the Year 2023

Aemetis Biogas Expands Revenues with First Sale of Low Carbon Fuel Standard Credits

NewMediaWire

a year ago

Aemetis Biogas Expands Revenues with First Sale of Low Carbon Fuel Standard Credits

Aris Water Solutions, Inc.'s (NYSE:ARIS) Intrinsic Value Is Potentially 94% Above Its Share Price

Simply Wall St.

a year ago

Aris Water Solutions, Inc.'s (NYSE:ARIS) Intrinsic Value Is Potentially 94% Above Its Share Price

NIU Q4 Sales Volume in China Sinks Over Economic Concerns

Zacks

a year ago

NIU Q4 Sales Volume in China Sinks Over Economic Concerns

Cardiol Therapeutics Announces it has Exceeded 50% Enrollment in its Phase II ARCHER Trial in Acute Myocarditis

Newsfile

a year ago

Cardiol Therapeutics Announces it has Exceeded 50% Enrollment in its Phase II ARCHER Trial in Acute Myocarditis

GeneDx Announces Preliminary 2023 Financial Results

GlobeNewswire

a year ago

GeneDx Announces Preliminary 2023 Financial Results

Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

AVITA Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

a year ago

AVITA Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference

AdTheorent Partners with Jounce Media to Verify Removal of Made for Advertising (MFA) Properties from Its Campaigns

PR Newswire

a year ago

AdTheorent Partners with Jounce Media to Verify Removal of Made for Advertising (MFA) Properties from Its Campaigns

$Apollomics Completes Enrollment in Phase 3 Bridging Study of Uproleselan in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia$

GlobeNewswire

a year ago

Apollomics Completes Enrollment in Phase 3 Bridging Study of Uproleselan in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia

11 Best Psychedelic Stocks to Buy in 2024

Insider Monkey

a year ago

11 Best Psychedelic Stocks to Buy in 2024

Pleasing Signs As A Number Of Insiders Buy Intevac Stock

Simply Wall St.

a year ago

Pleasing Signs As A Number Of Insiders Buy Intevac Stock

GeneDx Holdings Corp. (NASDAQ:WGS) Surges 52% Yet Its Low P/S Is No Reason For Excitement

Simply Wall St.

a year ago

GeneDx Holdings Corp. (NASDAQ:WGS) Surges 52% Yet Its Low P/S Is No Reason For Excitement

We Like These Underlying Return On Capital Trends At L.S. Starrett (NYSE:SCX)

Simply Wall St.

a year ago

We Like These Underlying Return On Capital Trends At L.S. Starrett (NYSE:SCX)

Pleasing Signs As A Number Of Insiders Buy GeneDx Holdings Stock

Simply Wall St.

a year ago

Pleasing Signs As A Number Of Insiders Buy GeneDx Holdings Stock

Under The Bonnet, iHuman's (NYSE:IH) Returns Look Impressive

Simply Wall St.

a year ago

Under The Bonnet, iHuman's (NYSE:IH) Returns Look Impressive

Cardiol Therapeutics Announces Massachusetts General Hospital, Largest Teaching Hospital of Harvard Medical School, as the 8th Major Medical Centre Participating in MAvERIC-Pilot

Newsfile

a year ago

Cardiol Therapeutics Announces Massachusetts General Hospital, Largest Teaching Hospital of Harvard Medical School, as the 8th Major Medical Centre Participating in MAvERIC-Pilot

WESTERN COPPER AND GOLD PROVIDES UPDATE ON THE PORT OF SKAGWAY

CNW Group

a year ago

WESTERN COPPER AND GOLD PROVIDES UPDATE ON THE PORT OF SKAGWAY

Dynagas LNG Partners LP Announces Results of 2023 Annual Meeting of Limited Partners

GlobeNewswire

a year ago

Dynagas LNG Partners LP Announces Results of 2023 Annual Meeting of Limited Partners

GOLDMINING INC. TARGETS EXPANSION AT THE SÃO JORGE GOLD PROJECT, BRAZIL

CNW Group

a year ago

GOLDMINING INC. TARGETS EXPANSION AT THE SÃO JORGE GOLD PROJECT, BRAZIL

Surmodics Announces TRANSCEND Trial 36-Month Data Presented at 50th Annual VEITH Symposium

Business Wire

a year ago

Surmodics Announces TRANSCEND Trial 36-Month Data Presented at 50th Annual VEITH Symposium

Cardiol Therapeutics Announces Study Results Presented at the 2023 Annual Meeting of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

Newsfile

a year ago

Cardiol Therapeutics Announces Study Results Presented at the 2023 Annual Meeting of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

L.B. Foster (FSTR) Q3 Earnings Miss Estimates, Revenues Beat

Zacks

a year ago

L.B. Foster (FSTR) Q3 Earnings Miss Estimates, Revenues Beat

2seventy bio Reports Third Quarter Financial Results and Recent Operational Progress

Business Wire

a year ago

2seventy bio Reports Third Quarter Financial Results and Recent Operational Progress

FitLife Brands Announces Third Quarter 2023 Results

GlobeNewswire

2 years ago

FitLife Brands Announces Third Quarter 2023 Results

City Office REIT, Inc. (NYSE:CIO) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

City Office REIT, Inc. (NYSE:CIO) Q3 2023 Earnings Call Transcript

Portman Ridge Finance Corporation (NASDAQ:PTMN) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Portman Ridge Finance Corporation (NASDAQ:PTMN) Q3 2023 Earnings Call Transcript

GuruFocus.com

2 years ago

SuRo Capital Corp. Reports Notable Increase in Net Asset Value for Q3 2023

SuRo Capital Corp. Reports Third Quarter 2023 Financial Results

GlobeNewswire

2 years ago

SuRo Capital Corp. Reports Third Quarter 2023 Financial Results

L.B. Foster Company (NASDAQ:FSTR) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

L.B. Foster Company (NASDAQ:FSTR) Q3 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

2 years ago

Q3 2023 Great Ajax Corp Earnings Call

GuruFocus.com

2 years ago

Great Ajax Corp (AJX) Reports Q3 2023 Earnings, Net Loss of $6.1 Million

Associated Press Finance

2 years ago

Great Ajax: Q3 Earnings Snapshot

Great Ajax Corp. Announces Results for the Quarter Ended September 30, 2023; Provides Strategic Update

Business Wire

2 years ago

Great Ajax Corp. Announces Results for the Quarter Ended September 30, 2023; Provides Strategic Update

Share on Social Networks: